Your route to market
We guide UCL academics, researchers and clinicians to get their research to market.
Explore innovations
Our portfolio and technologies span AI and quantum, to gene therapies to consumer products.
Global impact
How UCL research is changing the way the world lives, works and thrives.
Investors & business
Opportunities for collaboration across UCL's world-class research.
News & events
The latest news and events from our team and portfolio.
Get in touch
Contact our team of experts for all your queries and needs.
Real-world impact for people is at the heart of everything we do.
21 results
How licensing UCL nanopore research helped advance portable, real-time DNA and RNA sequencing.
Social Ventures
Empowering communities to have their voices heard.
An accessible digital tool designed to help people with neurological visual impairments read more confidently.
Real-world impact
Bringing together six academic and pharma powerhouses to bridge promising discoveries and commercial medicines.
Antibody drugs are in demand and abYsis is developing new ones for cancer, autoimmune diseases and more.
Educating families with proven methods to reduce childhood obesity.
Making progress with restoration of synapse communication with the body.
Using AI to help leading companies make efficiencies, from planning delivery routes to allocating staff.
Therapies to restore immune balance while suppressing harmful immune responses.
Developing pioneering gene therapy research from GOSH into rare disease treatments.
Using AI and space technology to improve detection and diagnosis of cancer - saving lives and reduce the devastating impact of missed symptoms.
A new treatment option for pancreatic cancer, with the potential to evade drug-resistance.
